SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg

Clinical trial NCT01227291 · COMPLETED

Trial details

NCT number: NCT01227291
Sponsor: Sylentis, S.A.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2010-10-01
Primary completion: 2012-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.